AMED Ventures, a venture capital based in the San Francisco Bay Area, believes in funding exceptional entrepreneurs and MedTech innovations that make a real impact on our lives.
Our team has years of experiences and proven track record in investment, business development, and operational management.
Our team has years of experiences and proven track record in investment, business development, and operational management.
Investment Type: Venture Capital
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 16.06.2026 | Rejoni | rejoni.com | $50M | United Sta... |
| 12.05.2023 | Sealonix | sealonix.com | $20M | United Sta... |
Mentions in press and media 7
| Date | Title | Description |
| 18.06.2026 | Rejoni Secures $25M for Uterine Health Innovation, Juveena System Nears Launch | Rejoni, a leading women's health company, secured $25 million. This substantial financing fuels the advanced development and market introduction of its Juveena Hydrogel System. Juveena aims to revolutionize uterine healing. It targets the r... |
| 16.06.2026 | Rejoni Secures $25 Million To Advance Juveena Hydrogel System Toward FDA Approval And Commercial Launch | Rejoni, a clinical-stage women’s health company focused on biomaterial therapies, announced the closing of a $25 million financing round to support the development and commercialization of the Juveena Hydrogel System. The financing included... |
| 16.06.2026 | Rejoni Raises $25M in Funding | Rejoni, Inc., a Bedford, MA-based clinical-stage company which specializes in uterine health, raised $25M in funding. Backers included Clavyst Bio, Amed Ventures, Ascension Ventures, Catalyst Health Ventures, Delos Capital, FemHealth Ventur... |
| 28.03.2025 | Supira Medical: $120 Million (Series E) Raised For Transforming The Percutaneous Ventricular Assist Device Market | Supira Medical – a clinical-stage Shifamed portfolio company – announced the completion of an oversubscribed Series E financing round, raising $120 million to accelerate the company’s mission of transforming the percutaneous ventricular ass... |
| 28.07.2024 | The Resurgence of Private Equity and Health Tech Investments | The world of finance is like a tide. It ebbs and flows, sometimes revealing treasures, sometimes hiding them. Recently, the tide has turned, bringing a wave of activity in private equity and health technology investments. The recent acquisi... |
| 28.07.2024 | The Race for Healthcare Investment: A New Era in Medical Capital | The healthcare landscape is shifting. Private equity firms are circling like hawks, eyeing lucrative investments in medical institutions. The Asian Institute of Medical Sciences (AIMS) in Faridabad is the latest prize. With a valuation of ₹... |
| 26.07.2024 | Imperative Care closes potential $150M Series E and more digital health fundings | Photo: Anchiy/Getty Images Medical technology company Imperative Care announced it initially closed an oversubscribed Series E financing round led by Ally Bridge Group. The company says additional closings of the round could bring its Serie... |